SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0000950123-10-054377
Filing Date
2010-06-01
Accepted
2010-05-28 21:34:57
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c01886e8vk.htm 425 42199
2 EXHIBIT 2.1 c01886exv2w1.htm EX-2.1 463115
3 EXHIBIT 10.1 c01886exv10w1.htm EX-10.1 48153
4 EXHIBIT 10.2 c01886exv10w2.htm EX-10.2 102611
5 EXHIBIT 10.3 c01886exv10w3.htm EX-10.3 128637
6 EXHIBIT 99.1 c01886exv99w1.htm EX-99.1 73429
7 EXHIBIT 99.2 c01886exv99w2.htm EX-99.2 33344
8 EXHIBIT 99.3 c01886exv99w3.htm EX-99.3 12991
  Complete submission text file 0000950123-10-054377.txt   906473
Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Filed by) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080
Business Address 379 OYSTER POINT SUITE 10 SOUTH SAN FRANCISCO CA 94080 (650) 624-1000
VAXGEN INC (Subject) CIK: 0001036968 (see all company filings)

IRS No.: 943236309 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-26483 | Film No.: 10867888
SIC: 2834 Pharmaceutical Preparations